← back to search

Emilia Anis

Israel Ministry of Health · IL
Area of research
Infectious Diseases · Health
Research interest
Research interests include Vaccine Coverage and Hesitancy, Viral gastroenteritis research and epidemiology, SARS-CoV-2 and COVID-19 Research, and Viral Infections and Immunology Research.
h-index
28
citations
4,151
works
94
NIH funding
primary concept
Medicine
email

Recent publications

Myocarditis After <i>BNT162b2</i> COVID-19 Third Booster Vaccine in Israel
Circulation 2022cited by 15position: middledoi
Reporting of Allergic Reactions During Pfizer-BioNTech BNTT162B2 Vaccination in Israel
The Journal of Allergy and Clinical Immunology In Practice 2022cited by 14position: firstdoi
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
The Lancet 2021cited by 1,746position: middledoi
Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study
The Lancet Infectious Diseases 2021cited by 134position: middledoi
A prolonged, nationwide measles outbreak despite very high vaccination coverage in Israel, 2018-19
Journal of Infection 2021cited by 28position: firstdoi
Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort study
EClinicalMedicine 2021cited by 28position: middledoi
Lessons from intensified surveillance of viral hepatitis A, Israel, 2017 and 2018
Eurosurveillance 2021cited by 9position: middledoi
Inferring Numbers of Wild Poliovirus Excretors Using Quantitative Environmental Surveillance
Vaccines 2021cited by 5position: middledoi
How compassionate use enabled Israel to deliver the Pfizer‐BioNTech COVID‐19 vaccination to vulnerable children aged 12–15 years before regulatory approval
Acta Paediatrica 2021cited by 5position: lastdoi
Tdap vaccination during pregnancy interrupts a twenty-year increase in the incidence of pertussis
Vaccine 2020cited by 16position: middledoi
Epidemiologic and phylogenetic analysis of the 2018 West Nile virus (WNV) outbreak in Israel demonstrates human infection of WNV lineage I
Eurosurveillance 2019cited by 14position: middledoi
Outbreak of human leptospirosis linked to contaminated water bodies in Northern Israel, June to August 2018
Eurosurveillance 2018cited by 19position: middledoi
Did two booster doses for schoolchildren change the epidemiology of pertussis in Israel?
Journal of Public Health Policy 2018cited by 6position: firstdoi
Ongoing hepatitis A among men who have sex with men (MSM) linked to outbreaks in Europe in Tel Aviv area, Israel, December 2016 – June 2017
Eurosurveillance 2017cited by 51position: middledoi
Spatial distribution of West Nile virus in humans and mosquitoes in Israel, 2000–2014
International Journal of Infectious Diseases 2017cited by 14position: middledoi
The Israeli public health response to wild poliovirus importation
The Lancet Infectious Diseases 2015cited by 51position: middledoi
The impact of a national routine immunisation programme initiated in 1999 on Hepatitis A incidence in Israel, 1993 to 2012
Eurosurveillance 2015cited by 40position: middledoi
How many OPV rounds are required to stop wild polio virus circulation in a developed country? Lessons from the Israeli experience
Vaccine 2015cited by 5position: middledoi
Laboratory Challenges in Response to Silent Introduction and Sustained Transmission of Wild Poliovirus Type 1 in Israel During 2013
The Journal of Infectious Diseases 2014cited by 34position: middledoi
Long-Term Predictors of Recurrent Laboratory-Confirmed Giardiasis: A 10-Year National Surveillance Study
Journal of the Pediatric Infectious Diseases Society 2014cited by 2position: lastdoi
Insidious reintroduction of wild poliovirus into Israel, 2013
Eurosurveillance 2013cited by 164position: firstdoi
West Nile fever in Israel: The reemergence of an endemic disease
Journal of Infection 2013cited by 32position: firstdoi
Estimated size of the population at risk of severe adverse events after smallpox vaccination in Israel
Vaccine 2012cited by 3position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ella Mendelson · Medical University of Graz12 papers (2013–2021) · 12 papers (2012–2021) · 7 papers (2012–2021) · 6 papers (2013–2021)Eran Kopel · University of Rochester Medical Center6 papers (2013–2015)Eric J. Haas · Ben-Gurion University of the Negev6 papers (2018–2021)Shepherd Roee Singer · Hebrew University of Jerusalem6 papers (2015–2021) · 5 papers (2013–2021)Sharon Alroy‐Preis · Israel Ministry of Health5 papers (2021–2022)Orna Mor · New South Wales Department of Health4 papers (2017–2021) · 4 papers (2013–2021) · 4 papers (2014–2021)Frederick J. Angulo · Pfizer (United States)3 papers (2021–2021) · 3 papers (2013–2015)Tamy Shohat · New York Medical College3 papers (2015–2017) · 3 papers (2018–2020)Gabriel Mircus · Pfizer (United States)3 papers (2021–2021) · 3 papers (2013–2018)Jo Southern · Pfizer (United States)3 papers (2021–2021) · 3 papers (2013–2019)